A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma
Damian A. Laber, Roseline I. Okeke, Carlos Arce-Lara, Beverly S. Taft, Cassandra L. Schonard, Kelly M. McMasters, Goetz H. Kloecker, Donald M. MillerVolume:
132
Language:
english
Pages:
6
DOI:
10.1007/s00432-006-0114-8
Date:
September, 2006
File:
PDF, 255 KB
english, 2006